| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $3.5B | $3.4B | $3.3B | $3.1B | $2.9B | $2.8B | $0.8B | $0.7B |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | $2.1B | $2.0B | $2.0B | $1.9B | $1.8B | $1.7B | $1.8B | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | — | — | — | — | — | — | — | — |
| Net Income | $0.3B | $0.0B | $0.2B | $0.8B | $0.5B | $0.9B | $0.1B | $0.1B |
| EPS (Basic) | $1.75 | $0.09 | $1.21 | $5.42 | $5.55 | $5.55 | $0.91 | $0.96 |
| EPS (Diluted) | $1.74 | $0.09 | $1.21 | $5.40 | $3.17 | $5.54 | $0.91 | $0.96 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $26.2B | $26.1B | $26.0B | $24.2B | $22.4B | $22.9B | $21.3B | $20.3B |
| Current Assets | — | — | — | — | — | — | — | — |
| Cash & Equivalents | $1.5B | $1.3B | $1.5B | $0.7B | $0.5B | $1.7B | $0.6B | $0.5B |
| Total Liabilities | $18.5B | $18.1B | $17.8B | $15.8B | $14.3B | $14.5B | $13.3B | $12.0B |
| Current Liabilities | — | — | — | — | — | — | — | — |
| Stockholders' Equity | $5.1B | $5.4B | $5.9B | $6.1B | $5.8B | $6.0B | $5.7B | $5.9B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $1.2B | $1.2B | $1.3B | $1.3B | $1.1B | $1.2B | $1.2B | $1.2B |
| Investing Cash Flow | $-0.6B | $-1.2B | $-1.2B | $-1.6B | $-1.0B | $-0.6B | $-1.0B | $-1.1B |
| Capital Expenditures | — | — | — | — | — | — | — | — |
| Financing Cash Flow | $-0.4B | $-0.3B | $0.8B | $0.6B | $-1.3B | $0.5B | $-0.1B | $0.1B |